Pamela Krueger
6PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.Min Zhu, Priyanka Madia, Alison Crawford
|Jul 31, 2024
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants.Yan Yang, Avvaru N Suhasini, Zaoli Jiang
|Jul 28, 2021
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade.John O DaSilva, Katie Yang, Oliver Surriga
|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.Janelle C Waite, Bei Wang, Lauric Haber
|Dec 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.Lynn E Macdonald, Karoline A Meagher, Matthew C Franklin
|Jun 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.Alison Crawford, Lauric Haber, Marcus P Kelly
Pageof 1
Frequent Collaborators
3 joint publications
Christopher Daly
3 joint publications
William Olson
2 joint publications
Alison Crawford
2 joint publications
Jennifer Finney
2 joint publications
Erica Ullman
2 joint publications
Elena Garnova
2 joint publications
Ashique Rafique
2 joint publications
Douglas MacDonald
2 joint publications
Lynn Macdonald
2 joint publications
Lauric Haber
